Article Information
PubMed
Published By
History
- Received January 22, 2015
- Revision received May 14, 2015
- Accepted June 3, 2015
- First published July 8, 2015.
- Version of record published July 8, 2015.
Copyright & Usage
Copyright © 2015 the authors 0270-6474/15/3510058-20$15.00/0
Author Information
View Full Text
Author contributions
Author contributions: N.P., A.G.K., and A.K. designed research; N.P., H.S., H.J., M.N., D.S.H., R.G., K.K., V.L., S.S., and J.L. performed research; N.P., H.J., and A.K. analyzed data; N.P., H.J., V.A., A.G.K., and A.K. wrote the paper.
Disclosures
- Received January 22, 2015.
- Revision received May 14, 2015.
- Accepted June 3, 2015.
This work was supported by National Institutes of Health Grants NS088206, ES10586, and NS78247, the W. Eugene and Linda Lloyd Endowed Chair to A.G.K., and the Dean Endowed Professorship to A.K. We thank Gary Zenitsky for assistance in preparing the manuscript.
A.G.K. and V.A. are shareholders of PK Biosciences Corporation (Ames, Iowa), which is interested in translating mechanistic studies into therapies targeting kinases, including Fyn. The remaining authors have no conflicts of interest.
- Correspondence should be addressed to Dr. Arthi Kanthasamy, Parkinson Disorders Research Laboratory, Department of Biomedical Sciences, 2016 Veterinary Medicine Building, Iowa State University, Ames, IA 50011. arthik{at}iastate.edu
Online Impact
